Marc Cerou

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Time-series analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 29, 2026
Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.

Marc Cerou, Christine Veyrat-Follet, Sophie Fliscounakis-Huynh

|Jan 26, 2018
Development and performance of npde for the evaluation of time-to-event models.

M Cerou, M Lavielle, K Brendel

Pageof 1